FDA

FDA panel backs highly controversial ALS drug in rare 2nd review

by

WASHINGTON (AP) — A panel of federal well being advisers voted Wednesday to advocate approval of an experimental drug to deal with Lou Gehrig’s illness, a exceptional turnaround for the extremely controversial drug which was beforehand rejected by the identical group earlier this yr. Meals and Drug Administration advisers voted 7 to 2 that Amylyx … Read more

FDA advisers recommend approval of controversial ALS drug

by

Unbiased advisers to the Meals and Drug Administration voted 7-2 on Wednesday to advocate approval of an experimental ALS drug with sturdy assist from sufferers and advocates, making it seemingly the extremely controversial therapy will likely be permitted by the company in a number of weeks. The vote was a surprising reversal from late March … Read more